LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lixte Biotechnology Holdings, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Lixte Biotechnology Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 2.25M shares, unchanged year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.25M 0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 2.25M +583K +35% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 2.25M -14.4M -86.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2.25M +585K +35.1% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 2.25M -14.4M -86.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.67M -15M -90% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 16.7M +2.91M +21.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.66M -12.1M -87.9% Dec 31, 2022 10-K 2024-03-19
Q3 2022 16.6M +2.9M +21.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 16.6M +2.98M +21.8% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 13.7M +208K +1.54% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 13.7M +1.34M +10.8% Dec 31, 2021 10-K 2023-03-29
Q3 2021 13.7M -53.3M -79.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 13.7M -53.4M -79.6% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 13.5M -53.5M -79.8% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 12.4M +1.23M +11% Dec 31, 2020 10-K 2022-03-21
Q3 2020 67M 0 0% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 67M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 67M 0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 11.2M -55.9M -83.3% Dec 31, 2019 10-K 2021-03-26
Q3 2019 67M +9M +15.5% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 67M +9.02M +15.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 67M +9.02M +15.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 67M +9.02M +15.5% Dec 31, 2018 10-K 2020-03-25
Q3 2018 58M +20K +0.03% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 58M +150K +0.26% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 58M +6.15M +11.9% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 58M +10.2M +21.2% Dec 31, 2017 10-K 2019-03-25
Q3 2017 58M +10.2M +21.2% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 57.9M +10M +20.9% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 51.9M +4M +8.36% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 47.9M 0 0% Dec 31, 2016 10-K 2018-03-23
Q3 2016 47.9M 0 0% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 47.9M +1M +2.13% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 47.9M +2.3M +5.05% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 47.9M +2.39M +5.26% Dec 31, 2015 10-K 2017-03-29
Q3 2015 47.9M +2.39M +5.26% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 46.9M +1.39M +3.06% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 45.6M +3.99M +9.6% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 45.5M +3.9M +9.38% Dec 31, 2014 10-K 2016-03-28
Q3 2014 45.5M +3.9M +9.38% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 45.5M +3.9M +9.38% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 41.6M 0 0% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 41.6M 0 0% Dec 31, 2013 10-K 2015-03-27
Q3 2013 41.6M 0 0% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 41.6M +142K +0.34% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 41.6M +6.22M +17.6% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 41.6M +6.32M +17.9% Dec 31, 2012 10-K 2014-03-21
Q3 2012 41.6M +6.32M +17.9% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 41.4M +6.18M +17.5% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 35.4M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 35.3M +182K +0.52% Dec 31, 2011 10-K 2013-03-15
Q3 2011 35.3M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 35.3M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 35.1M Dec 31, 2010 10-K 2012-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.